- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
GH Research (NASDAQ:GHRS), Quotes and News Summary
GH Research (NASDAQ: GHRS)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-14 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.111 | 0.0490 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
GH Research Questions & Answers
You can purchase shares of GH Research (NASDAQ: GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), CinCor Pharma (NASDAQ:CINC), Aerie Pharmaceuticals (NASDAQ:AERI) and DICE Therapeutics (NASDAQ:DICE).
The latest price target for GH Research (NASDAQ: GHRS) was reported by Roth Capital on Thursday, June 16, 2022. The analyst firm set a price target for 66.00 expecting GHRS to rise to within 12 months (a possible 500.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for GH Research (NASDAQ: GHRS) is $11 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for GH Research.
GH Research’s Q2 earnings are confirmed for Sunday, August 14, 2022.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.